BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27888884)

  • 1. Update on Burkitt Lymphoma.
    Dunleavy K; Little RF; Wilson WH
    Hematol Oncol Clin North Am; 2016 Dec; 30(6):1333-1343. PubMed ID: 27888884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burkitt lymphoma- a rare but challenging lymphoma.
    Casulo C; Friedberg JW
    Best Pract Res Clin Haematol; 2018 Sep; 31(3):279-284. PubMed ID: 30213397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols.
    Rohde M; Bonn BR; Zimmermann M; Lange J; Möricke A; Klapper W; Oschlies I; Szczepanowski M; Nagel I; Schrappe M; ; ; Loeffler M; Siebert R; Reiter A; Burkhardt B
    Haematologica; 2017 Jun; 102(6):1091-1098. PubMed ID: 28209658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burkitt lymphoma-related
    Yamazaki T; Liu L; Conlon EG; Manley JL
    RNA Biol; 2020 Oct; 17(10):1383-1390. PubMed ID: 32449435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sporadic and endemic Burkitt lymphoma have frequent
    Zhou P; Blain AE; Newman AM; Zaka M; Chagaluka G; Adlar FR; Offor UT; Broadbent C; Chaytor L; Whitehead A; Hall A; O'Connor H; Van Noorden S; Lampert I; Bailey S; Molyneux E; Bacon CM; Bomken S; Rand V
    Blood Adv; 2019 Jul; 3(14):2118-2127. PubMed ID: 31300419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.
    Schmitz R; Young RM; Ceribelli M; Jhavar S; Xiao W; Zhang M; Wright G; Shaffer AL; Hodson DJ; Buras E; Liu X; Powell J; Yang Y; Xu W; Zhao H; Kohlhammer H; Rosenwald A; Kluin P; Müller-Hermelink HK; Ott G; Gascoyne RD; Connors JM; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Ogwang MD; Reynolds SJ; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Pittaluga S; Wilson W; Waldmann TA; Rowe M; Mbulaiteye SM; Rickinson AB; Staudt LM
    Nature; 2012 Oct; 490(7418):116-20. PubMed ID: 22885699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ID3 mutations are recurrent events in double-hit B-cell lymphomas.
    Gebauer N; Bernard V; Feller AC; Merz H
    Anticancer Res; 2013 Nov; 33(11):4771-8. PubMed ID: 24222112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma.
    Wagener R; Seufert J; Raimondi F; Bens S; Kleinheinz K; Nagel I; Altmüller J; Thiele H; Hübschmann D; Kohler CW; Nürnberg P; Au-Yeung R; Burkhardt B; Horn H; Leoncini L; Jaffe ES; Ott G; Rymkiewicz G; Schlesner M; Russell RB; Klapper W; Siebert R
    Blood; 2019 Feb; 133(9):962-966. PubMed ID: 30567752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncanonical regulation of the Hedgehog mediator GLI1 by c-MYC in Burkitt lymphoma.
    Yoon JW; Gallant M; Lamm ML; Iannaccone S; Vieux KF; Proytcheva M; Hyjek E; Iannaccone P; Walterhouse D
    Mol Cancer Res; 2013 Jun; 11(6):604-15. PubMed ID: 23525267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approach to the Diagnosis and Treatment of Adult Burkitt's Lymphoma.
    Dunleavy K
    J Oncol Pract; 2018 Nov; 14(11):665-671. PubMed ID: 30423267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network and Computational Drug Repurposing Analysis for c-Myc Inhibition in Burkitt Lymphoma.
    Lee Y; Nam S
    Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):712-722. PubMed ID: 38035700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PCBP1 gene encoding poly(rC) binding protein I is recurrently mutated in Burkitt lymphoma.
    Wagener R; Aukema SM; Schlesner M; Haake A; Burkhardt B; Claviez A; Drexler HG; Hummel M; Kreuz M; Loeffler M; Rosolowski M; López C; Möller P; Richter J; Rohde M; Betts MJ; Russell RB; Bernhart SH; Hoffmann S; Rosenstiel P; Schilhabel M; Szczepanowski M; Trümper L; Klapper W; Siebert R; ;
    Genes Chromosomes Cancer; 2015 Sep; 54(9):555-64. PubMed ID: 26173642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low incidence of MYC/BCL2 double-hit in Burkitt lymphoma.
    Yoshida M; Ichikawa A; Miyoshi H; Kiyasu J; Kimura Y; Niino D; Ohshima K
    Pathol Int; 2015 Sep; 65(9):486-9. PubMed ID: 26182827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer: two in one.
    Berns A
    Nature; 2005 Aug; 436(7052):787-9. PubMed ID: 16094355
    [No Abstract]   [Full Text] [Related]  

  • 15. Pediatric B-Cell Lymphoma With Lymphoblastic Morphology, TdT Expression, MYC Rearrangement, and Features Overlapping With Burkitt Lymphoma.
    Meznarich J; Miles R; Paxton CN; Afify Z
    Pediatr Blood Cancer; 2016 May; 63(5):938-40. PubMed ID: 26785246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene-hypermutated isoforms of MYC protein: Tumour-suppressor P-53 protective-initiation of apoptosis that normally prevents Burkitt's lymphoma tumorigenesis can be enhanced.
    Wiseman A
    Med Hypotheses; 2006; 66(5):1046-7. PubMed ID: 16413684
    [No Abstract]   [Full Text] [Related]  

  • 17. Clonality Analysis of Immunoglobulin Gene Rearrangement by Next-Generation Sequencing in Endemic Burkitt Lymphoma Suggests Antigen Drive Activation of BCR as Opposed to Sporadic Burkitt Lymphoma.
    Amato T; Abate F; Piccaluga P; Iacono M; Fallerini C; Renieri A; De Falco G; Ambrosio MR; Mourmouras V; Ogwang M; Calbi V; Rabadan R; Hummel M; Pileri S; Leoncini L; Bellan C
    Am J Clin Pathol; 2016 Jan; 145(1):116-27. PubMed ID: 26712879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of MYC on malignant behavior.
    Ott G
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):100-6. PubMed ID: 25696841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recurrent clonally distinct Burkitt lymphoma case highlights genetic key events contributing to oncogenesis.
    Penther D; Viailly PJ; Latour S; Etancelin P; Bohers E; Vellemans H; Camus V; Menard AL; Coutant S; Lanic H; Lemasle E; Drieux F; Veresezan L; Ruminy P; Raimbault A; Soulier J; Frebourg T; Tilly H; Jardin F
    Genes Chromosomes Cancer; 2019 Aug; 58(8):595-601. PubMed ID: 30779244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants.
    Hemann MT; Bric A; Teruya-Feldstein J; Herbst A; Nilsson JA; Cordon-Cardo C; Cleveland JL; Tansey WP; Lowe SW
    Nature; 2005 Aug; 436(7052):807-11. PubMed ID: 16094360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.